At IXICO, we are committed to transforming the landscape of Parkinson’s Disease research through advanced neuroimaging and biomarker analytics. Our AI-powered platform delivers precise and actionable insights to support the understanding, diagnosis, and treatment of PD.
Key Technology and Service Features
|
- Precision in Neuroscience - Our platform delivers precision across medicine, imaging, insights, analytics, care, technology, data, results, and research—empowering breakthroughs in Parkinson’s Disease.
- Advanced Technology The IXICO Platform is at the forefront of neuroimaging innovation, enhancing the evaluation of drug safety, patient eligibility, and therapeutic efficacy in Parkinson’s clinical trials.
- End-to-End Solutions We provide comprehensive solutions—from scientific protocol definition to site setup, data acquisition, image reading, analysis, quality control, and secure data transfer—streamlining the research process.
- Technology Excellence Our platform captures and quantifies PD-relevant biomarkers with high accuracy, paving the way for the next generation of regulatory-grade imaging biomarkers.
- Scientific Excellence We translate cutting-edge neuroscience into validated, regulatorily compliant biomarkers that are essential for leadership and progress in Parkinson’s research.
- Service Excellence We simplify the logistical and scientific complexities of neuroimaging, enabling our clients to focus on discovery, development, and clinical implementation in Parkinson’s Disease.
|